StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.09−0.02 (-1.80%)

Close on Nov 19, 2026Market cap $78.80MP/E –Yield –

InflaRx operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2023 it was -€44.91M.

Annual operating income

PeriodPeriod endValueChange
FY2023Dec 31, 2023-€44.91M–
FY2022Dec 31, 2022-€32.24M–
FY2021Dec 31, 2021-€47.63M–

More InflaRx figures

See a number that looks wrong?